NCT03666260

Brief Summary

Patients are painful after total hip arthroplasty. These patients have significant co-morbidities. Analgesics cause significant side effects in this population. Locoregional analgesia is therefore an effective means of reducing the consumption of opioids in this surgery. The "gold standard" of locoregional analgesia after Total Hip Arthroplasty is the femoral block. However, a new technique has recently been described: the Quadratus Lumborum Block. The comparison of these two techniques is lacking in the literature. The comparison of the Quadratus Lumborum Block to the femoral block in Total Hip arthroplasty is important in the analgesic strategy of patients undergoing this surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
179

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 11, 2018

Completed
27 days until next milestone

Study Start

First participant enrolled

October 8, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 9, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 9, 2021

Completed
Last Updated

May 16, 2024

Status Verified

May 1, 2024

Enrollment Period

1.8 years

First QC Date

September 10, 2018

Last Update Submit

May 15, 2024

Conditions

Keywords

Total hip replacement surgerypost operative painquadratus lumborum blockfemoral block

Outcome Measures

Primary Outcomes (1)

  • morphine consumption

    Morphine consumption during the 24 hours postoperative

    24 hours

Study Arms (2)

Quadratus Lumborum Block arm

EXPERIMENTAL
Procedure: Quadratus Lumborum Block

Femoral block arm

ACTIVE COMPARATOR
Procedure: femoral block

Interventions

Quadratus Lumborum Block with echography

Quadratus Lumborum Block arm
femoral blockPROCEDURE

femoral block with echography

Femoral block arm

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients eligible for total hip replacement surgery in Reims University Hospital
  • Patients agreeing to participate in the research and having signed informed consent
  • between 18 yo and 95 yo
  • Patients affiliated to a social security system

You may not qualify if:

  • Patients with allergy to local anesthetics
  • Patients with neuropathy
  • Patients with an ASA score of 4
  • Patients undergoing revision surgery for total hip arthroplasty
  • Patients receiving anterior hip total hip replacement surgery
  • Patients with a contraindication to the realization of the quadratus lumborum block, femoral block or spinal anesthesia (clinical coagulopathy, infection at the point of puncture ...)
  • Patients refusing the proposed techniques

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Damien JOLLY

Reims, France

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2018

First Posted

September 11, 2018

Study Start

October 8, 2018

Primary Completion

July 9, 2020

Study Completion

July 9, 2021

Last Updated

May 16, 2024

Record last verified: 2024-05

Locations